Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Dow
Moodys
Colorcon
McKesson
Express Scripts

Last Updated: February 2, 2023

Vorinostat - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What are the generic drug sources for vorinostat and what is the scope of freedom to operate?

Vorinostat is the generic ingredient in one branded drug marketed by Msd Sub Merck and is included in one NDA. There are nine patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Vorinostat has one hundred and thirty-two patent family members in thirty-five countries.

There are two drug master file entries for vorinostat. One supplier is listed for this compound.

Summary for vorinostat
International Patents:132
US Patents:9
Tradenames:1
Applicants:1
NDAs:1
Drug Master File Entries: 2
Finished Product Suppliers / Packagers: 1
Raw Ingredient (Bulk) Api Vendors: 131
Clinical Trials: 276
Patent Applications: 7,184
Formulation / Manufacturing:see details
What excipients (inactive ingredients) are in vorinostat?vorinostat excipients list
DailyMed Link:vorinostat at DailyMed
Recent Clinical Trials for vorinostat

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Kyunghee Burkitt, DO, PhDPhase 2
Medical College of WisconsinPhase 1
National Institute of Neurological Disorders and Stroke (NINDS)Phase 2

See all vorinostat clinical trials

Pharmacology for vorinostat

US Patents and Regulatory Information for vorinostat

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Msd Sub Merck ZOLINZA vorinostat CAPSULE;ORAL 021991-001 Oct 6, 2006 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Msd Sub Merck ZOLINZA vorinostat CAPSULE;ORAL 021991-001 Oct 6, 2006 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Msd Sub Merck ZOLINZA vorinostat CAPSULE;ORAL 021991-001 Oct 6, 2006 RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
Msd Sub Merck ZOLINZA vorinostat CAPSULE;ORAL 021991-001 Oct 6, 2006 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for vorinostat

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Msd Sub Merck ZOLINZA vorinostat CAPSULE;ORAL 021991-001 Oct 6, 2006 See Plans and Pricing See Plans and Pricing
Msd Sub Merck ZOLINZA vorinostat CAPSULE;ORAL 021991-001 Oct 6, 2006 See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for vorinostat

Country Patent Number Title Estimated Expiration
Australia 2006249440 Formulations of suberoylanilide hydroxamic acid and methods for producing same See Plans and Pricing
Taiwan I365068 See Plans and Pricing
Denmark 1663194 See Plans and Pricing
Mexico PA04008577 METODOS PARA INDUCIR DIFERENCIACION TERMINAL. (METHODS OF INDUCING TERMINAL DIFFERENTIATION.) See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Baxter
Dow
McKesson
Merck
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.